Key result
Quinidine shows up to ~10-fold greater hypotensive potency than procainamide, with mixed cardiac effects.
Why the study?
The cardiovascular effects of quinidine and procainamide on intact dogs and isolated canine atria were not fully characterized.
What are the chronotropic, inotropic, and hypotensive effects of quinidine and procainamide in intact dogs and isolated canine atria?
What are the chronotropic, inotropic, and hypotensive effects of quinidine and procainamide in intact dogs and isolated canine atria?
Answers are grounded in this paper and cite their sources.
Quinidine and procainamide exhibit complex, dose-dependent cardiac-depressant and -stimulating properties in canine models, with quinidine showing greater hypotensive potency and a tendency to induce tachycardia.
The effects of quinidine and procainamide were studied in isolated canine atria cross-perfused with heparinized arterial blood from donor dogs as well as in these donor dogs. When administered intravenously to donor dogs, both drugs produced dose-related hypotensive effects, but quinidine was 3-10 times more potent than procainamide. Quinidine frequently caused tachycardia in the donor dogs, while procainamide usually produced bradycardia. Quinidine-induced tachycardia was partially suppressed by vagotomy and completely inhibited or changed to bradycardia after propranolol. In isolated atria, small doses of drugs caused slight negative chronotropic and inotropic effects, frequently accompanied by small and short-lasting increases in contractile force and heart rate. Only decreases in contractile force and rate were observed with large doses. Administration of quinidine and procainamide into the sinus node artery of the isolated atrium induced negative, biphasic, or triphasic changes in chronotropism and inotropism. In isolated atria, quinidine and verapamil depressed the contractile force to a greater extent at higher stimulation frequencies. Procainamide showed less of this effect, because atrial muscle became unresponsive to high-frequency pacing with the larger doses of procainamide. These results suggest that quinidine and procainamide have both cardiac-depressant and -stimulating properties.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (1982) studied this question. Quinidine and procainamide was evaluated on Cardiovascular effects including hypotension, chronotropism, and inotropism. Quinidine and procainamide produced dose-related hypotensive effects in dogs, with quinidine being 3-10 times more potent, and both drugs exhibited cardiac-depressant and -stimulating properties.
Synapse has enriched 10 related papers. Consider them for comparative context: